Evogene (EVGN) Gross Margin (2016 - 2025)
Historic Gross Margin for Evogene (EVGN) over the last 14 years, with Q3 2025 value amounting to 49.68%.
- Evogene's Gross Margin rose 95600.0% to 49.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 49.3%, marking a year-over-year decrease of 213700.0%. This contributed to the annual value of 57.32% for FY2024, which is 126800.0% down from last year.
- According to the latest figures from Q3 2025, Evogene's Gross Margin is 49.68%, which was up 95600.0% from 84.62% recorded in Q2 2025.
- Evogene's Gross Margin's 5-year high stood at 92.6% during Q1 2024, with a 5-year trough of 5.19% in Q2 2021.
- Over the past 5 years, Evogene's median Gross Margin value was 40.11% (recorded in 2024), while the average stood at 43.83%.
- Its Gross Margin has fluctuated over the past 5 years, first soared by 428400bps in 2024, then plummeted by -586400bps in 2025.
- Over the past 5 years, Evogene's Gross Margin (Quarter) stood at 14.15% in 2021, then skyrocketed by 217bps to 44.85% in 2022, then plummeted by -31bps to 31.14% in 2023, then soared by 71bps to 53.13% in 2024, then dropped by -7bps to 49.68% in 2025.
- Its Gross Margin stands at 49.68% for Q3 2025, versus 84.62% for Q2 2025 and 33.96% for Q1 2025.